Use of spironolactone in dermatology.
Study Design
- Çalışma Türü
- Review
- Popülasyon
- pregnant women
- Müdahale
- Use of spironolactone in dermatology. None
- Karşılaştırıcı
- None
- Birincil Sonuç
- hair loss
- Etki Yönü
- Positive
- Yanlılık Riski
- Unclear
Abstract
Spironolactone has been used as a potassium-sparing diuretic for more than 30 years. It is a synthetic 17-lactone steroid and primarily acts as an aldosterone antagonist. Since the accidental discovery of its antiandrogenic effects, it has been used in the treatment of many dermatologic conditions in which androgen plays a role in the pathogenesis. Antiandrogenic effects of spironolactone are exerted by reducing testosterone production and inhibiting its action on the target tissues. Spironolactone is used as a primary medical treatment for hirsutism and female pattern hair loss. Continuous treatment is required to sustain the effect. It is an effective alternative treatment for acne in women. It has the benefit of a long-term safety profile. Spironolactone should not be used in pregnancy due to its teratogenic effects and is not used in men due to the risk of feminization.
Kısaca
Spironolactone is used as a primary medical treatment for hirsutism and female pattern hair loss and an effective alternative treatment for acne in women and has the benefit of a long-term safety profile.
Used In Evidence Reviews
Similar Papers
Journal of the American Academy of Dermatology · 2005
Evaluation and treatment of male and female pattern hair loss.
The British journal of dermatology · 2005
Treatment of female pattern hair loss with oral antiandrogens.
International journal of dermatology · 2018
Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone.
International journal of women's dermatology · 2018
Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review.
Dermatologic clinics · 1998
Hair regrowth. Therapeutic agents.
International journal of nanomedicine · 2014